Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard G Bach

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
The American Journal of Cardiology|November 13, 2019
Incremental Cost of Acute Kidney Injury after Percutaneous Coronary Intervention in the United StatesAmit P Amin, Christian McNeely, John A Spertus, et al.
Circulation|February 10, 2012
Admission international normalized ratio levels, early treatment strategies, and major bleeding risk among non-ST-segment-elevation myocardial infarction patients on home warfarin therapy: insights from the National Cardiovascular Data RegistrySumeet Subherwal, Eric D Peterson, Anita Y Chen, et al.
Journal of the American College of Cardiology|April 2, 2013
Nuisance bleeding with prolonged dual antiplatelet therapy after acute myocardial infarction and its impact on health statusAmit P Amin, Alok Bachuwar, Kimberly J Reid, et al.
European Heart Journal|October 23, 2014
Risk model for estimating the 1-year risk of deferred lesion intervention following deferred revascularization after fractional flow reserve assessmentJeremiah P Depta, Jayendrakumar S Patel, Eric Novak, et al.
Circulation|April 1, 2009
Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding ScoreSumeet Subherwal, Richard G Bach, Anita Y Chen, et al.
Circulation. Cardiovascular Interventions|July 13, 2021
Transradial Access for High-Risk Percutaneous Coronary Intervention: Implications of the Risk-Treatment ParadoxAmit P Amin, Sunil V Rao, Arnold H Seto, et al.
European Heart Journal|April 1, 2014
The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trialSteen Husted, Stefan K James, Richard G Bach, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 8, 2014
Conversations in cardiology: bridging antiplatelet therapy before surgeryMorton J Kern, Robert J Applegate, Malcolm Bell, et al.
The American Journal of Cardiology|December 9, 2019
Improving Care Pathways for Acute Coronary Syndrome: Patients Undergoing Percutaneous Coronary InterventionAmit P Amin, John A Spertus, Hemant Kulkarni, et al.
Journal of the American College of Cardiology|May 30, 2020
Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic CardiomyopathyCarolyn Y Ho, Matthew E Mealiffe, Richard G Bach, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
The American Journal of Cardiology|November 13, 2019
Incremental Cost of Acute Kidney Injury after Percutaneous Coronary Intervention in the United StatesAmit P Amin, Christian McNeely, John A Spertus, et al.
Circulation|February 10, 2012
Admission international normalized ratio levels, early treatment strategies, and major bleeding risk among non-ST-segment-elevation myocardial infarction patients on home warfarin therapy: insights from the National Cardiovascular Data RegistrySumeet Subherwal, Eric D Peterson, Anita Y Chen, et al.
Journal of the American College of Cardiology|April 2, 2013
Nuisance bleeding with prolonged dual antiplatelet therapy after acute myocardial infarction and its impact on health statusAmit P Amin, Alok Bachuwar, Kimberly J Reid, et al.
European Heart Journal|October 23, 2014
Risk model for estimating the 1-year risk of deferred lesion intervention following deferred revascularization after fractional flow reserve assessmentJeremiah P Depta, Jayendrakumar S Patel, Eric Novak, et al.
Circulation|April 1, 2009
Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding ScoreSumeet Subherwal, Richard G Bach, Anita Y Chen, et al.
Circulation. Cardiovascular Interventions|July 13, 2021
Transradial Access for High-Risk Percutaneous Coronary Intervention: Implications of the Risk-Treatment ParadoxAmit P Amin, Sunil V Rao, Arnold H Seto, et al.
European Heart Journal|April 1, 2014
The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trialSteen Husted, Stefan K James, Richard G Bach, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 8, 2014
Conversations in cardiology: bridging antiplatelet therapy before surgeryMorton J Kern, Robert J Applegate, Malcolm Bell, et al.
The American Journal of Cardiology|December 9, 2019
Improving Care Pathways for Acute Coronary Syndrome: Patients Undergoing Percutaneous Coronary InterventionAmit P Amin, John A Spertus, Hemant Kulkarni, et al.
Journal of the American College of Cardiology|May 30, 2020
Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic CardiomyopathyCarolyn Y Ho, Matthew E Mealiffe, Richard G Bach, et al.
Pageof 7